BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24959179)

  • 1. A new case of syringocystadenocarcinoma papilliferum: a rare pathology for a wide-ranging comprehension.
    Paradiso B; Bianchini E; Cifelli P; Cavazzini L; Lanza G
    Case Rep Med; 2014; 2014():453874. PubMed ID: 24959179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature.
    Lee KG; Choi W; Lim JS; Hahn HJ; Myung KB; Cheong SH
    Ann Dermatol; 2019 Oct; 31(5):559-562. PubMed ID: 33911649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genital syringocystadenocarcinoma papilliferum: An unusual location and review of the literature.
    Shahidi Dadras M; Baghani M; Rakhshan A; Ansari Djafari A; Abdollahimajd F
    Urol Case Rep; 2022 Jan; 40():101934. PubMed ID: 34820287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringocystadenocarcinoma Papilliferum of External Auditory Canal: First Case Report in English Literature.
    Verma RR; Verma R
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):3700-3705. PubMed ID: 36742756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringocystadenocarcinoma Papilliferum in the Perianal Area.
    Iga N; Fujii H; Miyake T; Ehara M; Kore-Eda S
    Case Rep Dermatol; 2015; 7(2):84-9. PubMed ID: 26078737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syringocystadenocarcinoma papilliferum: a systematic review of clinical characteristics, reappraisal of associations, diagnostic pitfalls and management challenges.
    Wan L; Park A; Khachemoune A
    Arch Dermatol Res; 2024 Jun; 316(7):421. PubMed ID: 38904691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases.
    Zhang Y; Kong YY; Cai X; Shen XX; Kong JC
    J Cutan Pathol; 2017 Jun; 44(6):538-543. PubMed ID: 28337777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevus Sebaceous of the Scalp With Stepwise Progression Into Invasive Syringocystadenocarcinoma Papilliferum.
    Kneitz H; Goebeler M; Rütten A
    Am J Dermatopathol; 2021 Dec; 43(12):965-969. PubMed ID: 34797792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature.
    Halsey JN; Faith EF; Logan SJ; Shenoy A; Schieffer KM; Cottrell CE; Lillis AP; Aldrink JH; Setty BA; Pearson GD
    Case Rep Dermatol Med; 2022; 2022():8076649. PubMed ID: 35154835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review.
    McBride JD; Billings SD; Komforti MK
    J Cutan Pathol; 2021 Nov; 48(11):1387-1391. PubMed ID: 34089523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
    Arslan H; Diyarbakrl M; Batur S; Demirkesen C
    J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic Syringocystadenocarcinoma Papilliferum: A Case Report, Tumor Genomic Profiling, and Literature Review.
    Altunel E; Perepletchikov A; Kozyreva O
    Case Rep Oncol Med; 2020; 2020():9056209. PubMed ID: 32850165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringocystadenocarcinoma papilliferum in a linear nevus verrucosus.
    Hoekzema R; Leenarts MF; Nijhuis EW
    J Cutan Pathol; 2011 Feb; 38(2):246-50. PubMed ID: 19758371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart.
    Ishida-Yamamoto A; Sato K; Wada T; Takahashi H; Iizuka H
    J Am Acad Dermatol; 2001 Nov; 45(5):755-9. PubMed ID: 11606929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy in a Case of Malignant Syringocystadenocarcinoma Papilliferum of Vulva with Locoregional Failure.
    Rao PB; Ghosh S; Mohapatra M; Philip NP; Kumar PR; Manam S; Karra P; Jasti VK
    Case Rep Oncol Med; 2015; 2015():638294. PubMed ID: 26697249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.
    Parekh V; Guerrero CE; Knapp CF; Elmets CA; McKay KM
    Am J Dermatopathol; 2016 Jan; 38(1):56-62. PubMed ID: 26317389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Syringocystadenocarcinoma Papilliferum: Not Your Usual Suspect.
    Bashinskaya A; Shapiro L; Thompson C; Truett AP; Moody P
    Cureus; 2023 May; 15(5):e39424. PubMed ID: 37362529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
    Peterson J; Tefft K; Blackmon J; Rajpara A; Fraga G
    Dermatol Online J; 2013 Sep; 19(9):19620. PubMed ID: 24050294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringocystadenocarcinoma papilliferum: a case report.
    Park SH; Shin YM; Shin DH; Choi JS; Kim KH
    J Korean Med Sci; 2007 Aug; 22(4):762-5. PubMed ID: 17728526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringocystadenocarcinoma papilliferum with locoregional metastases.
    Satter E; Grady D; Schlocker CT
    Dermatol Online J; 2014 Apr; 20(4):22335. PubMed ID: 24746298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.